48,830
edits
Difference between revisions of "Diffuse large B-cell lymphoma"
Jump to navigation
Jump to search
Diffuse large B-cell lymphoma (view source)
Revision as of 01:53, 12 June 2013
, 01:53, 12 June 2013no edit summary
| Line 8: | Line 8: | ||
| LMDDx = [[follicular lymphoma]], [[Hodgkin lymphoma]], [[PTLD]], primary effusion lymphoma, carcinoma | | LMDDx = [[follicular lymphoma]], [[Hodgkin lymphoma]], [[PTLD]], primary effusion lymphoma, carcinoma | ||
| Stains = | | Stains = | ||
| IHC = CD20+, CD10+, BCL6+, CD45+ | | IHC = CD20+, CD10+/-, BCL6+/-, CD45+ | ||
| EM = | | EM = | ||
| Molecular = t(14;18)(q32;q21)/IGH-BCL2 - esp. when arising from follicular lymphoma | | Molecular = t(14;18)(q32;q21)/IGH-BCL2 - esp. when arising from follicular lymphoma | ||
| Line 20: | Line 20: | ||
| Symptoms = | | Symptoms = | ||
| Prevalence = | | Prevalence = | ||
| Bloodwork = | | Bloodwork = +/- cytopenia | ||
| Rads = | | Rads = lymphadenopathy | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = | | Prognosis = poor | ||
| Other = | | Other = | ||
| ClinDDx = metastatic carcinoma, reactive lymphadenopathy, infective lymphadenopathy}} | | ClinDDx = metastatic carcinoma, reactive lymphadenopathy, infective lymphadenopathy}} | ||